AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company has a strong portfolio in areas such as oncology, cardiovascular, renal & metabolism, and respiratory diseases. AstraZeneca's commitment to research and development has enabled it to bring innovative therapies to market, contributing to its growth and reputation. However, the company faces significant challenges, including stringent regulatory environments, competition from other pharmaceutical companies, and the high cost of drug development. As the healthcare landscape evolves, AstraZeneca has opportunities to expand its market presence through strategic partnerships, digital health initiatives, and entry into emerging markets. Nevertheless, the company must navigate potential threats such as patent expirations, pricing pressures, and geopolitical uncertainties.